NCT03614988

Brief Summary

A study designed to compare evening versus morning levothyroxine intake in the elderly.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 30, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 3, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

October 14, 2019

Status Verified

October 1, 2019

Enrollment Period

1.6 years

First QC Date

July 30, 2018

Last Update Submit

October 11, 2019

Conditions

Keywords

PolypharmacyElderly

Outcome Measures

Primary Outcomes (1)

  • Variation in TSH (Thyroid-Stimulating Hormone) levels.

    Variation in TSH (Thyroid-Stimulating Hormone) levels after 24 weeks of levothyroxine use in the evening compared to the morning period.

    24 weeks.

Secondary Outcomes (3)

  • Prevalence of drugs with potential drug interaction with levothyroxine.

    24 weeks

  • Level of TSH (Thyroid-Stimulating Hormone) control in each group.

    24 weeks

  • TSH (Thyroid-Stimulating Hormone) levels of the patients at baseline

    Baseline (0 weeks)

Study Arms (2)

Morning Levothyroxine Intake First

ACTIVE COMPARATOR

Randomized patients to receive levothyroxine in the morning and after crossover to Evening Levothyroxine Administration.

Other: Evening Levothyroxine Administration

Evening Levothyroxine Intake First

EXPERIMENTAL

Randomized patients to receive levothyroxine in the morning and after crossover to Morning Levothyroxine Administration.

Other: Morning Levothyroxine Administration

Interventions

Bedtime levothyroxine intake, with 60-minute meal-free interval

Also known as: Bedtime Levothyroxine Administration
Morning Levothyroxine Intake First

Morning levothyroxine intake, 60 minutes before breakfast.

Also known as: Before Breakfast Levothyroxine Administration
Evening Levothyroxine Intake First

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 60 years or older who consult at the Geriatrics, Endocrinology and Internal Medicine Clinic at Hospital Clinicas de Porto Alegre
  • Patients diagnosed with Primary Hypothyroidism
  • Patients on levothyroxine for at least 6 months
  • Patients with the same dose of levothyroxine for at least 3 months

You may not qualify if:

  • Severe Dementia
  • Severe Congestive Heart Failure (NYHA IV or / and three or more hospitalizations for heart failure within 1-year interval)
  • Diagnosis of Advanced Stage Neoplasia
  • Diagnosis of Thyroid Cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

RECRUITING

Related Publications (1)

  • Giassi K, Piccoli V, da Costa Rodrigues T, Gorga Bandeira de Mello R. Evaluation of evening versus morning levothyroxine intake in elderly (MONIALE). Trials. 2019 Dec 17;20(1):742. doi: 10.1186/s13063-019-3816-3.

MeSH Terms

Conditions

Hypothyroidism

Condition Hierarchy (Ancestors)

Thyroid DiseasesEndocrine System Diseases

Study Officials

  • Renato Gorga Bandeira de Mello

    Professor of the Post Graduate Program in Endocrinology at the Hospital de Clinicas de Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Renato Gorga Bandeira de Mello

CONTACT

Karina Karina Giassi

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2018

First Posted

August 3, 2018

Study Start

May 1, 2018

Primary Completion

November 30, 2019

Study Completion

March 31, 2020

Last Updated

October 14, 2019

Record last verified: 2019-10

Locations